199 related articles for article (PubMed ID: 35116481)
21. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
Vaughan TL; Farrow DC; Hansten PD; Chow WH; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Rotterdam H; Dubrow R; Ahsan H; West AB; Blot WJ; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
[TBL] [Abstract][Full Text] [Related]
22. [Esophageal adenocarcinoma: What can be the cause of substantially rising incidence?].
Horváth ÖP; Vereczkei A
Orv Hetil; 2021 Dec; 162(51):2040-2046. PubMed ID: 34898468
[TBL] [Abstract][Full Text] [Related]
23. Stanniocalcin-1 inhibits renal ischemia/reperfusion injury via an AMP-activated protein kinase-dependent pathway.
Pan JS; Huang L; Belousova T; Lu L; Yang Y; Reddel R; Chang A; Ju H; DiMattia G; Tong Q; Sheikh-Hamad D
J Am Soc Nephrol; 2015 Feb; 26(2):364-78. PubMed ID: 25012175
[TBL] [Abstract][Full Text] [Related]
24. Human Tonsil-Derived Mesenchymal Stromal Cells Maintain Proliferating and ROS-Regulatory Properties via Stanniocalcin-1.
Seo Y; Shin TH; Ahn JS; Oh SJ; Shin YY; Yang JW; Park HY; Shin SC; Kwon HK; Kim JM; Sung ES; Park GC; Lee BJ; Kim HS
Cells; 2020 Mar; 9(3):. PubMed ID: 32155780
[TBL] [Abstract][Full Text] [Related]
25. [Reflux of duodenal or gastroduodenal contents induces esophageal carcinoma in rats].
Miwa K; Miyashita T; Hattori T
Nihon Rinsho; 2004 Aug; 62(8):1433-8. PubMed ID: 15344531
[TBL] [Abstract][Full Text] [Related]
26. Involvement of luminal nitric oxide in the pathogenesis of the gastroesophageal reflux disease spectrum.
Iijima K; Shimosegawa T
J Gastroenterol Hepatol; 2014 May; 29(5):898-905. PubMed ID: 24863184
[TBL] [Abstract][Full Text] [Related]
27. Gastroesophageal reflux and cancer.
Turcotte S; Duranceau A
Thorac Surg Clin; 2005 Aug; 15(3):341-52. PubMed ID: 16104125
[TBL] [Abstract][Full Text] [Related]
28. The 3-deoxysappanchalcone induces ROS-mediated apoptosis and cell cycle arrest via JNK/p38 MAPKs signaling pathway in human esophageal cancer cells.
Kwak AW; Lee MJ; Lee MH; Yoon G; Cho SS; Chae JI; Shim JH
Phytomedicine; 2021 Jun; 86():153564. PubMed ID: 33895649
[TBL] [Abstract][Full Text] [Related]
29. From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.
Wang RH
World J Gastroenterol; 2015 May; 21(17):5210-9. PubMed ID: 25954094
[TBL] [Abstract][Full Text] [Related]
30. Impact of inflammation-metaplasia-adenocarcinoma sequence and prevention in surgical rat models.
Miyashita T; Shah FA; Miwa K; Sasaki S; Nishijima K; Oyama K; Ninomiya I; Fushida S; Fujimura T; Hattori T; Harmon JW; Ohta T
Digestion; 2013; 87(1):6-11. PubMed ID: 23343962
[TBL] [Abstract][Full Text] [Related]
31. Esophageal acid exposure at pH < or = 2 is more common in Barrett's esophagus patients and is associated with oxidative stress.
Dvorak K; Fass R; Dekel R; Payne CM; Chavarria M; Dvorakova B; Bernstein H; Bernstein C; Garewal H
Dis Esophagus; 2006; 19(5):366-72. PubMed ID: 16984534
[TBL] [Abstract][Full Text] [Related]
32. The resistance of esophageal adenocarcinoma to bile salt insult is associated with manganese superoxide dismutase expression.
Schiffman SC; Li Y; Xiao D; Li X; Aiyer HS; Martin RC
J Surg Res; 2011 Dec; 171(2):623-30. PubMed ID: 20638682
[TBL] [Abstract][Full Text] [Related]
33. Deoxycholic acid at neutral and acid pH, is genotoxic to oesophageal cells through the induction of ROS: The potential role of anti-oxidants in Barrett's oesophagus.
Jenkins GJ; D'Souza FR; Suzen SH; Eltahir ZS; James SA; Parry JM; Griffiths PA; Baxter JN
Carcinogenesis; 2007 Jan; 28(1):136-42. PubMed ID: 16905748
[TBL] [Abstract][Full Text] [Related]
34. Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model.
Bonde P; Sui G; Dhara S; Wang J; Broor A; Kim IF; Wiley JE; Marti G; Duncan M; Jaffee E; Montgomery E; Maitra A; Harmon JW
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):763-9. PubMed ID: 17320581
[TBL] [Abstract][Full Text] [Related]
35. Different redox states in malignant and nonmalignant esophageal epithelial cells and differential cytotoxic responses to bile acid and honokiol.
Chen G; Izzo J; Demizu Y; Wang F; Guha S; Wu X; Hung MC; Ajani JA; Huang P
Antioxid Redox Signal; 2009 May; 11(5):1083-95. PubMed ID: 19187006
[TBL] [Abstract][Full Text] [Related]
36. The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: the role of deoxycholic acid.
Roesly HB; Khan MR; Chen HD; Hill KA; Narendran N; Watts GS; Chen X; Dvorak K
Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G864-72. PubMed ID: 22301112
[TBL] [Abstract][Full Text] [Related]
37. Human stanniocalcin-1 suppresses angiotensin II-induced superoxide generation in cardiomyocytes through UCP3-mediated anti-oxidant pathway.
Liu D; Huang L; Wang Y; Wang W; Wehrens XH; Belousova T; Abdelrahim M; DiMattia G; Sheikh-Hamad D
PLoS One; 2012; 7(5):e36994. PubMed ID: 22693564
[TBL] [Abstract][Full Text] [Related]
38. Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.
Neto AG; Whitaker A; Pei Z
Semin Oncol; 2016 Feb; 43(1):86-96. PubMed ID: 26970127
[TBL] [Abstract][Full Text] [Related]
39. Expression of the putative stem cell marker Musashi-1 in Barrett's esophagus and esophageal adenocarcinoma.
Bobryshev YV; Freeman AK; Botelho NK; Tran D; Levert-Mignon AJ; Lord RV
Dis Esophagus; 2010 Sep; 23(7):580-9. PubMed ID: 20459440
[TBL] [Abstract][Full Text] [Related]
40. The role of bile acids in the neoplastic progression of Barrett's esophagus - a short representative overview.
Jürgens S; Meyer F; Spechler SJ; Souza R
Z Gastroenterol; 2012 Sep; 50(9):1028-34. PubMed ID: 22965634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
